Patent · US Active

Materials and methods relating to fusion proteins for inducing an immune response

US7410643B2 · kind B2 · utility

0Cited by
1References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 10, 2007
Grant dateAug 12, 2008
Priority date
Expiry dateJan 10, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/13022
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A nucleic acid construct is provided for delivery into living cells in vivo for inducing an immune response in a patient to an antigen; the construct directing the expression of a fusion protein, said fusion protein comprising said antigen and an adjuvant sequence derived from a plant viral coat protein. Methods for making constructs and methods of using such constructs for the treatment of infectious disease, cancer and B cell malignancy, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.